Suppr超能文献

疫苗学中的问题:当前挑战与未来方向。

Issues in vaccinology: Present challenges and future directions.

作者信息

Sheerin Dylan, Openshaw Peter Jm, Pollard Andrew J

机构信息

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.

the NIHR Oxford Biomedical Research Centre.

出版信息

Eur J Immunol. 2017 Dec;47(12):2017-2025. doi: 10.1002/eji.201746942. Epub 2017 Sep 27.

Abstract

Vaccination is a principal and highly cost-effective means of controlling infectious diseases, providing direct protection against pathogens by conferring long-lasting immunological memory and inducing population-level herd immunity. Despite rapid ongoing progress in vaccinology, there remain many obstacles to the development and deployment of novel or improved vaccines; these include the underlying science of how to induce and sustain appropriate protective immune responses as well as bureaucratic, logistic and socio-political hurdles. The failure to distribute and administer existing vaccines to at-risk communities continues to account for a large proportion of infant mortality worldwide: almost 20 million children do not have access to basic vaccines and several million still die each year as a result. While emerging epidemic or pandemic diseases pose a significant threat to global health and prosperity, there are many infectious diseases which provide a continuous or cyclical burden on healthcare systems which also need to be addressed. Gaps in knowledge of the human immune system stand in the way of developing technologies to overcome individual and pathogenic variation. The challenges in tackling infectious disease and directions that the field of preventive medicine may take to improve the current picture of global health are the focus of this review.

摘要

疫苗接种是控制传染病的主要且极具成本效益的手段,通过赋予持久的免疫记忆和诱导群体水平的 herd 免疫来直接抵御病原体。尽管疫苗学领域目前正在迅速取得进展,但新型或改良疫苗的研发和推广仍存在许多障碍;这些障碍包括如何诱导和维持适当的保护性免疫反应的基础科学,以及官僚、后勤和社会政治方面的障碍。未能将现有疫苗分发和接种到高危社区,仍然是全球婴儿死亡的很大一部分原因:近 2000 万儿童无法获得基本疫苗,每年仍有数百万人因此死亡。虽然新出现的流行病或大流行病对全球健康和繁荣构成重大威胁,但许多传染病也给医疗系统带来持续或周期性负担,也需要加以应对。人类免疫系统知识的空白阻碍了开发克服个体和病原体变异的技术。应对传染病的挑战以及预防医学领域为改善当前全球健康状况可能采取的方向是本综述的重点。

相似文献

1
Issues in vaccinology: Present challenges and future directions.
Eur J Immunol. 2017 Dec;47(12):2017-2025. doi: 10.1002/eji.201746942. Epub 2017 Sep 27.
5
[Novel vaccines. Vaccinations in the near and distant future].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Nov;52(11):1083-90. doi: 10.1007/s00103-009-0953-y.
6
Vaccines for the world: major challenges for the future.
Southeast Asian J Trop Med Public Health. 1997;28 Suppl 2:122-6.
8
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Oct 10;43(10):1515-1544. doi: 10.3760/cma.j.cn112338-20220825-00734.
9
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Oct 6;56(10):1356-1386. doi: 10.3760/cma.j.cn112150-20220825-00840.
10
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity.
Curr Opin Infect Dis. 2023 Jun 1;36(3):171-176. doi: 10.1097/QCO.0000000000000916. Epub 2023 Mar 20.

引用本文的文献

2
Nanoclays: Promising Materials for Vaccinology.
Vaccines (Basel). 2022 Sep 17;10(9):1549. doi: 10.3390/vaccines10091549.
3
Moving beyond Titers.
Vaccines (Basel). 2022 Apr 26;10(5):683. doi: 10.3390/vaccines10050683.
6
Advances in the Development of Anti- Vaccines: Challenges, Opportunities, and Perspectives.
Vaccines (Basel). 2020 Sep 22;8(3):555. doi: 10.3390/vaccines8030555.
7
Preventing infectious diseases for healthy ageing: The VITAL public-private partnership project.
Vaccine. 2020 Aug 18;38(37):5896-5904. doi: 10.1016/j.vaccine.2020.07.005. Epub 2020 Jul 24.
8
'It takes two to tango': Bridging the gap between country need and vaccine product innovation.
PLoS One. 2020 Jun 10;15(6):e0233950. doi: 10.1371/journal.pone.0233950. eCollection 2020.
9
Adjuvant activity of -derived mycolic acids.
Heliyon. 2020 May 27;6(5):e04064. doi: 10.1016/j.heliyon.2020.e04064. eCollection 2020 May.
10
Abundance in Early Infancy and Vaccine Response at 2 Years of Age.
Pediatrics. 2019 Feb;143(2). doi: 10.1542/peds.2018-1489.

本文引用的文献

3
Prospects for preventing infant invasive GBS disease through maternal vaccination.
Vaccine. 2017 Aug 16;35(35 Pt A):4457-4460. doi: 10.1016/j.vaccine.2017.02.025. Epub 2017 Feb 23.
4
Targeting women with free cervical cancer screening: challenges and lessons learnt from Osun state, southwest Nigeria.
Pan Afr Med J. 2016 Aug 19;24:319. doi: 10.11604/pamj.2016.24.319.9300. eCollection 2016.
5
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.
N Engl J Med. 2016 Sep 15;375(11):1019-32. doi: 10.1056/NEJMoa1603800.
6
Advances in RSV vaccine research and development - A global agenda.
Vaccine. 2016 Jun 3;34(26):2870-2875. doi: 10.1016/j.vaccine.2016.03.109. Epub 2016 Apr 19.
7
Why don't we have an effective tuberculosis vaccine yet?
Expert Rev Vaccines. 2016 Aug;15(8):1009-13. doi: 10.1586/14760584.2016.1170599. Epub 2016 May 3.
10
The March towards a Vaccine for Congenital CMV: Rationale and Models.
PLoS Pathog. 2016 Feb 11;12(2):e1005355. doi: 10.1371/journal.ppat.1005355. eCollection 2016 Feb.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验